Series B - OMass Therapeutics
Investment Firm
Overview
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
Announced Date
May 15, 2023
Funding Type
Series B
Highlights
Location
Europe
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
OMass Therapeutics raised $12524893 on 2023-05-15 in Series B
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 14, 2016 |  Seed Round - OMass Therapeutics | 1 | - | 1.4M |
| Feb 17, 2020 | Series A - OMass Therapeutics | 2 | - | 35.8M |
| Apr 27, 2022 | Series B - OMass Therapeutics | 6 | - | 94.7M |
| May 15, 2023 | Series B - OMass Therapeutics | 1 | - | 12.5M |
Recent Activity
There is no recent news or activity for this profile.